Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Johnson and Johnson
Covington
Boehringer Ingelheim
Moodys
Citi
Medtronic
Merck

Generated: April 26, 2018

DrugPatentWatch Database Preview

ELESTAT Drug Profile

« Back to Dashboard

Which patents cover Elestat, and what generic alternatives are available?

Elestat is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in ELESTAT is epinastine hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the epinastine hydrochloride profile page.
Summary for ELESTAT
Drug patent expirations by year for ELESTAT
Synonyms for ELESTAT
(13bRS)-9,13b-Dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride
108929-04-0
3-Amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine monohydrochloride
3-Amino-9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepine Hydrochloride
80012-43-7 (Parent)
80012-44-8
9,13b-Dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepin-3-amine Hydrochloride
9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepin-3-amine, monohydrochloride
9,13b-Dihydro-1H-dibenz[cf]imidazo[1,5-a]azepine hydrochloride
9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride
AC-1491
AC1L4HSC
AKOS015967222
Alesion
Alesion (TN)
AN-14853
ANW-43039
BC220918
C16H15N3.HCl
C16H16ClN3
CAS-108929-04-0
CCG-221805
CHEBI:51037
CHEMBL1200491
CTK8B3730
D01713
DE-114
DSSTox_CID_26502
DSSTox_GSID_46502
DSSTox_RID_81671
DTXSID1046502
E0799
Elestat (TN)
Epinastin HCl
epinastin hydrochloride
Epinastine HCl
Epinastine hydrochloride
Epinastine hydrochloride (JAN)
Epinastine hydrochloride [JAN]
Epinastine hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard
Epinastine hydrochloride, >=98% (HPLC), solid
Epinastine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Epinastine monohydrochloride
Epinastinehydrochloride
EX-A1004
Flurinol
FT-0631049
FT-0700527
HMS3652N21
IH-Dibenz(c,f)imidazo(1,5-a)azepin-3-amine, 9,13b-dihydro-, hydrochloride
IH-Dibenz(c,f)imidazo(1,5-a)azepin-3-amine, 9,13b-dihydro-, monohydrochloride
J-002209
KS-1159
LP00501
LS-60567
MFCD00865648
MFCD00933434
MolPort-005-940-901
NCGC00165791-02
NCGC00165791-04
NCGC00261186-01
PubChem1940
Relestat
RTR-002009
s4253
SCHEMBL122749
Tox21_112263
Tox21_112263_1
Tox21_500501
TR-002009
VKXSGUIOOQPGAF-UHFFFAOYSA-N
WAL 801 CL
WAL 801CL
WAL-801CL

US Patents and Regulatory Information for ELESTAT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan ELESTAT epinastine hydrochloride SOLUTION/DROPS;OPHTHALMIC 021565-001 Oct 16, 2003 AT RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ELESTAT
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Ophthalmic Solution 0.05% ➤ Subscribe 2008-10-14

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Moodys
US Army
Accenture
Merck
Express Scripts
Boehringer Ingelheim
Queensland Health
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.